School of Medicine

​With more than $5 million in new grants from Susan G. Komen for the Cure, Washington University scientists at the Alvin J. Siteman Cancer Center are developing innovative treatments in the fight against breast cancer.

A new study shows the same gene variations that make it difficult to stop smoking also increase the likelihood that heavy smokers will respond to nicotine-replacement therapy and drugs that thwart cravings. The finding suggests it may one day be possible to predict which patients are most likely to benefit from drug treatments for nicotine addiction.

Ralph G. Dacey Jr., MD, the Henry G. and Edith R. Schwartz Professor and head of the Department of Neurosurgery at Washington University School of Medicine in St. Louis, became president of the Society of Neurological Surgeons (SNS) May 22, 2012.

St. Jude Children’s Research Hospital–Washington University Pediatric Cancer Genome Project has announced the largest release to date of comprehensive human cancer genome data for free access by the global scientific community.

Pediatric ophthalmologist R. Lawrence Tychsen, MD, has been named the John F. Hardesty, MD, Distinguished Professor of Ophthalmology and Visual Sciences at Washington University School of Medicine in St. Louis.

A study by Brooke Winner, MD (pictured), and Jeff Peipert, MD, to evaluate birth control methods has found dramatic differences in their effectiveness. Women who used birth control pills, the patch or vaginal ring were 20 times more likely to have an unintended pregnancy than those who used longer-acting forms such as an intrauterine device (IUD) or implant.

Larry J. Shapiro, MD, executive vice chancellor for medical affairs and dean of the School of Medicine, congratulates Kristen E. Ziara Harring, as he hands her her Doctor of Medicine degree at the School of Medicine Commencement Recognition Ceremony May 18 at the America’s Center. At the ceremony, 127 students received degrees.

Researchers at Washington University School of Medicine in St. Louis have received a $3 million grant from the National Cancer Institute (NCI) to develop a triple threat in the fight against cancer: a single virus equipped to find, image and kill cancer cells, all at once.

A new recommendation issued today by the U.S. Preventive Services Task Force against routine PSA testing for healthy men age 50 and older goes too far, says a prostate cancer expert at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis.

A less invasive screening test for colorectal cancer reduces deaths from the disease but is probably not as effective as colonoscopy, the gold standard.